"Even in that population, retatrutide demonstrated nearly 21 percent average weight loss at the highest dose, which is remarkable." Retatrutide Also Delivered Significant Results for People With Severe Obesity and Heart Disease The other trial, TRIUMPH-3, included nearly 2,000 adults with severe obesity (defined as a BMI of 40 or higher) and cardiovascular disease
These deposits persist despite consistent lifestyle efforts
49 A recent systematic review and meta-analysis involving obese individuals without diabetes demonstrated that tirzepatide, semaglutide, liraglutide, and exenatide significantly increased the risk of GI adverse events compared with placebo
Response varies widely between individuals, partly due to differences in how patients metabolize bupropion and respond to dopaminergic stimulation
FDA Adverse Event Reporting System (FAERS) data may include reports of musculoskeletal symptoms in patients using GLP-1 receptor agonists, though these reports do not establish causation and may reflect coincidental timing rather than a true drug effect
Will my blood sugar drop if I drink alcohol on tirzepatide
